Ming‐Yi Chiang

506 total citations
8 papers, 411 citations indexed

About

Ming‐Yi Chiang is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Ming‐Yi Chiang has authored 8 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Surgery. Recurrent topics in Ming‐Yi Chiang's work include Immune Cell Function and Interaction (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Ming‐Yi Chiang is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Ming‐Yi Chiang collaborates with scholars based in United States. Ming‐Yi Chiang's co-authors include A. John MacLennan, Michel Khrestchatisky, Allan J. Tobin, Catia Sternini, R W Olsen, Wentao Xu, Meyer B. Jackson, Nicholas C. Brecha, Niranjala J.K. Tillakaratne and Joseph R. Podojil and has published in prestigious journals such as Neuron, The Journal of Immunology and Journal of Neurochemistry.

In The Last Decade

Ming‐Yi Chiang

7 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Yi Chiang United States 7 262 253 59 49 33 8 411
Kyoko Ibaraki Japan 10 207 0.8× 211 0.8× 42 0.7× 28 0.6× 14 0.4× 16 424
Larissa A. Jarzylo United States 7 261 1.0× 299 1.2× 26 0.4× 31 0.6× 15 0.5× 8 515
Miguel A. Chinchetru Spain 12 292 1.1× 322 1.3× 26 0.4× 24 0.5× 25 0.8× 28 537
Xuye Hu China 4 130 0.5× 167 0.7× 33 0.6× 48 1.0× 12 0.4× 5 428
Roberta Sala Italy 11 236 0.9× 198 0.8× 19 0.3× 22 0.4× 20 0.6× 15 429
Marta Cantero Spain 10 113 0.4× 386 1.5× 29 0.5× 29 0.6× 12 0.4× 16 579
Anna E. Cook Australia 8 108 0.4× 195 0.8× 53 0.9× 29 0.6× 44 1.3× 9 385
Stephanie Urschel Germany 10 233 0.9× 646 2.6× 55 0.9× 32 0.7× 12 0.4× 11 748
P. Jeanette Simpson United States 10 125 0.5× 285 1.1× 23 0.4× 14 0.3× 34 1.0× 13 499

Countries citing papers authored by Ming‐Yi Chiang

Since Specialization
Citations

This map shows the geographic impact of Ming‐Yi Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Yi Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Yi Chiang more than expected).

Fields of papers citing papers by Ming‐Yi Chiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Yi Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Yi Chiang. The network helps show where Ming‐Yi Chiang may publish in the future.

Co-authorship network of co-authors of Ming‐Yi Chiang

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Yi Chiang. A scholar is included among the top collaborators of Ming‐Yi Chiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Yi Chiang. Ming‐Yi Chiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Podojil, Joseph R., Ming‐Yi Chiang, G. Schulz, et al.. (2025). AA147 Alleviates Symptoms in a Mouse Model of Multiple Sclerosis by Reducing Oligodendrocyte Loss. Glia. 73(6). 1241–1257.
2.
Piunti, Andrea, Khyati Meghani, Yanni Yu, et al.. (2022). Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma. Science Advances. 8(40). eabo8043–eabo8043. 31 indexed citations
3.
Podojil, Joseph R., Andrew C. Cogswell, Ming‐Yi Chiang, et al.. (2022). Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy. Frontiers in Immunology. 13. 887649–887649. 11 indexed citations
4.
Podojil, Joseph R., Ming‐Yi Chiang, Tobias Neef, et al.. (2022). Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice. The Journal of Immunology. 209(3). 465–475. 17 indexed citations
5.
Podojil, Joseph R., Alexander P. Glaser, Elise T. Courtois, et al.. (2020). Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma. OncoImmunology. 9(1). 1744897–1744897. 30 indexed citations
6.
Winger, Ryan C., Christopher Harp, Ming‐Yi Chiang, et al.. (2016). Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell–Mediated Central Nervous System Autoimmune Disease. The Journal of Immunology. 196(4). 1443–1448. 25 indexed citations
7.
Khrestchatisky, Michel, A. John MacLennan, Niranjala J.K. Tillakaratne, Ming‐Yi Chiang, & Allan J. Tobin. (1991). Sequence and Regional Distribution of the mRNA Encoding the α2 Polypeptide of Rat γ‐Aminobutyric AcidA Receptors. Journal of Neurochemistry. 56(5). 1717–1722. 62 indexed citations
8.
Khrestchatisky, Michel, A. John MacLennan, Ming‐Yi Chiang, et al.. (1989). A novel α subunit in rat brain GABAA receptors. Neuron. 3(6). 745–753. 235 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026